Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Cell

• Publication date

  2024-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cell.2024.01.016PMID 38364782PMCID 10935576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Emerging insights into alternative end-joining: Mechanisms, genome instability and therapeutic opportunities in cancer (Review)

  2025cites this paper
• Proteogenomic characterization reveals that lipid droplet formation promotes esophageal squamous cell cancer progression.

  2025cites this paper
• The 2024 Report on the Human Proteome from the HUPO Human Proteome Project.

  2024cites this paper
• Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications

  2024cites this paper
• N6‐Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases

  2024cites this paper
• CTR-DB 2.0: an updated cancer clinical transcriptome resource, expanding primary drug resistance and newly adding acquired resistance datasets and enhancing the discovery and validation of predictive biomarkers

  2024cites this paper
• Comprehensive bioinformatics analysis of co-mutation of FLG2 and TP53 reveals prognostic effect and influences on the immune infiltration in ovarian serous cystadenocarcinoma

  2023cites this paper